Toggle navigation
Home
Search
Services
Blog
Contact
About
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M.
Ceregene, Inc., San Diego, CA, United States
Search 3 grants from Katherine Bishop
Search grants from Ceregene, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Quality of Care and Patient Experience in GeriPACT: A Comparative Effectiveness Study
Gene Regulation and DNA Damage in the Aging Brain
Drug Free Communities Support Program
Genetic Study of Radiation Resistance
Exceptional Financial Need Schollarship
Recently added grants:
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges
Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges
Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
3R44NS044652-02S1
Application #
6844444
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Murphy, Diane
Project Start
2002-09-30
Project End
2005-08-31
Budget Start
2003-09-30
Budget End
2004-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$199,878
Indirect Cost
Institution
Name
Ceregene, Inc.
Department
Type
DUNS #
019139414
City
San Diego
State
CA
Country
United States
Zip Code
92121
Related projects
NIH 2004
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bartus, Raymond / Ceregene, Inc.
$157,635
NIH 2004
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M. / Ceregene, Inc.
$199,878
NIH 2003
R44 NS
Nerve Growth Factor Delivery for Alzheimer's Disease
Bishop, Katherine M. / Ceregene, Inc.
$701,862
Publications
Bishop, Kathie M; Hofer, Eva K; Mehta, Arpesh et al.
(2008)
Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons.
Exp Neurol 211:574-84
Comments
Be the first to comment on Katherine Bishop's grant